Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
Determining patient-oncologist cancer treatment intent concordance using systematic screening in a supportive care center.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Ancy Kayley M, Ann-Yi Sujin, Huang Yi, Andersen Clark R, Heung Yvonne, Singleton Grecia Aldana, Bruera Eduardo, Hui David, Zhukovsky Donna S
Аннотация
PURPOSE: Accurate illness understanding is a necessary component of goal-concordant care. Few prior studies have investigated systematic screening for illness understanding. The objectives of this study were to determine the extent of agreement between patient-reported and oncologist-documented cancer treatment intent using systematic screening and to explore the association between such agreement and patient characteristics.
METHODS: We implemented illness understanding screening for patients who presented to our supportive care center (SCC). We compared patient responses regarding chance of cure and primary treatment goal on a survey administered at their initial consultation visit with the oncologist-documented treatment intent in the electronic health record.
RESULTS: The analysis included 300 patients (mean age, 59 years); most were women (56%), were White (80.3%), and had advanced disease (78%). Regarding concordance, 152 (50.7%) patients had concordant treatment intent (cure, n = 64; non-cure, n = 88), and 148 (49.3%) patients had discordant treatment intent, with 98.6% (n = 146) of patients with discordant treatment intent inaccurately reporting a treatment intent of cure. Patients with discordant treatment intent were more likely to be Black (OR = 3.13, p = 0.02), have a primary cancer site of "other" (mostly melanoma and sarcoma) (OR = 2.30, p = 0.04), have advanced disease (OR = 6.25, p < 0.001), and report lower spiritual pain (OR = 0.88, p = 0.04).
CONCLUSION: The rate of inaccuracy in patient-reported curability perception and primary treatment goal at our SCC is high, supporting the need for systematic screening and communication interventions to improve illness understanding and provide goal-concordant care.
METHODS: We implemented illness understanding screening for patients who presented to our supportive care center (SCC). We compared patient responses regarding chance of cure and primary treatment goal on a survey administered at their initial consultation visit with the oncologist-documented treatment intent in the electronic health record.
RESULTS: The analysis included 300 patients (mean age, 59 years); most were women (56%), were White (80.3%), and had advanced disease (78%). Regarding concordance, 152 (50.7%) patients had concordant treatment intent (cure, n = 64; non-cure, n = 88), and 148 (49.3%) patients had discordant treatment intent, with 98.6% (n = 146) of patients with discordant treatment intent inaccurately reporting a treatment intent of cure. Patients with discordant treatment intent were more likely to be Black (OR = 3.13, p = 0.02), have a primary cancer site of "other" (mostly melanoma and sarcoma) (OR = 2.30, p = 0.04), have advanced disease (OR = 6.25, p < 0.001), and report lower spiritual pain (OR = 0.88, p = 0.04).
CONCLUSION: The rate of inaccuracy in patient-reported curability perception and primary treatment goal at our SCC is high, supporting the need for systematic screening and communication interventions to improve illness understanding and provide goal-concordant care.